14 April 2022 : Database Analysis
Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study
Zhi-Zhao Li12ABCDEF*, Xin Du2A, Nian Liu2A, Xue-yuan Guo2A, Chao Jiang2A, Liu He2C, Shi-jun Xia2A, Wei Wang2A, Ri-bo Tang2A, San-shuai Chang2A, Rong-hui Yu2A, De-yong Long2A, Rong Bai2A, Cai-hua Sang2A, Song-nan Li2A, Jian-zeng Dong2A, Chang-sheng Ma2ADOI: 10.12659/MSM.934747
Med Sci Monit 2022; 28:e934747
Figure 1 (A1, A2) Stroke/thromboembolism and cardiovascular mortality-free survival rate by quartile (Q) of LDL-C without oral anticoagulants (OAC). (Q1, <1.95; Q2, 1.95–2.51; Q3, 2.52–3.09; and Q4 >3.09 mmol/L). (B) Stroke/thromboembolism and cardiovascular mortality-free survival rate by quartile of LDL-C with OAC.